Monday, December 17, 2012
HCV Transplant Studies GS-7977 Also Telaprevir & Boceprevir
New From NATAP
Telaprevir & Boceprevir in Liver Transplantation
Telaprevir therapy required tacrolimus dose reduction in liver transplant recipients with HCV -
GS-7977 HCV Transplant Studies
Telaprevir Post Liver Transplant
Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: A 12-week pilot study providing safety and efficacy data
Boceprevir HCV Liver Transplant
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment